Brief: Poseida Therapeutics Announces FDA Clearance Of Investigational New Drug Application For P-CD19CD20-ALLO1, An Allogeneic Dual Car-T Cell Therapy For B-Cell Malignancies
05/07/2023 13:14
July 5 (Reuters) - Poseida Therapeutics Inc PSTX.O :
* POSEIDA THERAPEUTICS ANNOUNCES FDA CLEARANCE OF
INVESTIGATIONAL
NEW DRUG APPLICATION FOR P-CD19CD20-ALLO1, AN ALLOGENEIC DUAL
CAR-T CELL THERAPY FOR B-CELL MALIGNANCIES
Source text for Eikon: ID:nPn9Pv3nXa
Further company coverage: PSTX.O
((reuters.briefs@thomsonreuters.com;))